PhiChem Corporation
300398.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | CN¥2,918 | CN¥2,729 | CN¥2,907 | CN¥2,627 |
| % Growth | 6.9% | -6.1% | 10.6% | – |
| Cost of Goods Sold | CN¥1,913 | CN¥1,792 | CN¥1,765 | CN¥1,582 |
| Gross Profit | CN¥1,005 | CN¥936 | CN¥1,142 | CN¥1,045 |
| % Margin | 34.4% | 34.3% | 39.3% | 39.8% |
| R&D Expenses | CN¥182 | CN¥189 | CN¥184 | CN¥193 |
| G&A Expenses | CN¥268 | CN¥303 | CN¥246 | CN¥209 |
| SG&A Expenses | CN¥430 | CN¥438 | CN¥396 | CN¥337 |
| Sales & Mktg Exp. | CN¥162 | CN¥136 | CN¥150 | CN¥128 |
| Other Operating Expenses | CN¥85 | CN¥157 | CN¥68 | CN¥37 |
| Operating Expenses | CN¥696 | CN¥785 | CN¥647 | CN¥567 |
| Operating Income | CN¥308 | CN¥151 | CN¥495 | CN¥478 |
| % Margin | 10.6% | 5.5% | 17% | 18.2% |
| Other Income/Exp. Net | -CN¥3 | -CN¥0 | -CN¥2 | -CN¥4 |
| Pre-Tax Income | CN¥305 | CN¥151 | CN¥493 | CN¥474 |
| Tax Expense | CN¥33 | CN¥15 | CN¥50 | CN¥73 |
| Net Income | CN¥247 | CN¥112 | CN¥435 | CN¥386 |
| % Margin | 8.4% | 4.1% | 15% | 14.7% |
| EPS | 0.47 | 0.21 | 0.84 | 0.756 |
| % Growth | 123.8% | -75% | 11.1% | – |
| EPS Diluted | 0.47 | 0.21 | 0.84 | 0.756 |
| Weighted Avg Shares Out | 525 | 535 | 517 | 510 |
| Weighted Avg Shares Out Dil | 525 | 535 | 517 | 510 |
| Supplemental Information | – | – | – | – |
| Interest Income | CN¥18 | CN¥20 | CN¥13 | CN¥15 |
| Interest Expense | CN¥54 | CN¥68 | CN¥68 | CN¥78 |
| Depreciation & Amortization | CN¥184 | CN¥178 | CN¥146 | CN¥121 |
| EBITDA | CN¥532 | CN¥459 | CN¥686 | CN¥605 |
| % Margin | 18.2% | 16.8% | 23.6% | 23% |